Basic research<BR>Glial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase

Hitoshi Funahashi; Hirozumi Sawai; Akira Yasuda; Nobuo Ochi; Hiroki Takahashi; Yoichi Matsuo; Takehiro Wakasugi; Hiromitsu Takeyama

eISSN: 1896-9151
ISSN: 1734-1922

Archives of Medical Science

Current issue Archive Special issues Abstracting and indexing Subscription

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2007
vol. 3

Send email

Copy url:

abstract:

Basic research
Glial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase

Hitoshi Funahashi

,

Hirozumi Sawai

,

Akira Yasuda

,

Nobuo Ochi

,

Hiroki Takahashi

,

Yoichi Matsuo

,

Takehiro Wakasugi

,

Hiromitsu Takeyama

Arch Med Sci 2007; 3, 4: 323-329

Online publish date: 2008/01/09

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Funahashi H, Sawai H, Yasuda A, et al. Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase. Archives of Medical Science. 2007;3(4):323-329.

APA

Funahashi, H., Sawai, H., Yasuda, A., Ochi, N., Takahashi, H.,  & Matsuo, Y. et al. (2007). Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase. Archives of Medical Science, 3(4), 323-329.

Chicago

Funahashi, Hitoshi, Hirozumi Sawai, Akira Yasuda, Nobuo Ochi, Hiroki Takahashi, Yoichi Matsuo,  and Takehiro Wakasugi et al. 2007. "Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase". Archives of Medical Science 3 (4): 323-329.

Harvard

Funahashi, H., Sawai, H., Yasuda, A., Ochi, N., Takahashi, H., Matsuo, Y., Wakasugi, T.,  and Takeyama, H. (2007). Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase. Archives of Medical Science, 3(4), pp.323-329.

MLA

Funahashi, Hitoshi et al. "Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase." Archives of Medical Science, vol. 3, no. 4, 2007, pp. 323-329.

Vancouver

Funahashi H, Sawai H, Yasuda A, Ochi N, Takahashi H, Matsuo Y et al. Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase. Archives of Medical Science. 2007;3(4):323-329.

Introduction: Tumour invasion and metastasis consist of multiple steps involving changes in proliferation, motility, adhesion, invasion, and secretion of certain enzymes. Cancer cell invasion calls for the action of several proteinases that degrade the extracellular matrix and basement membranes. For several decades, matrix metalloproteinases (MMP) have been thought to be cancer-related proteinases, and recent reports have revealed that the plasminogen activator (uPA) system plays an important role in cancer cell viability.
Material and methods: The casein zymography procedure was used to determine uPA activity in the human pancreatic cancer cell lines BxPC-3, HPAF-II, and MIA PaCa-2. Gelatinase activity of cell culture supernatants was determined by gelatin zymography. Proliferation of pancreatic cancer cells was monitored using an MTT assay and cell counting. Invasive behavior was examined using a Matrigel double-chamber assay.
Results: The uPA activity of HPAF-II cells was the strongest of all the cells examined, and HPAF-II only showed both high molecular weight (HMW) and low molecular weight (LMW) uPA. GDNF enhanced the invasive ability of pancreatic cancer cells that expressed the components of the plasminogen activator system. This effect was inhibited by a specific uPA inhibitor. Furthermore, GDNF increased MMP activities, and the uPA inhibitor partially inhibited MMP activities.
Conclusions: The present study suggests that the plasminogen activator system plays an essential role in pancreatic cancer cell invasion. Activation of uPA by GDNF enhanced the invasive ability of pancreatic cancer cells and also increased the expression of active MMPs.

keywords:

Basic researchGlial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase

Hitoshi Funahashi , Hirozumi Sawai , Akira Yasuda , Nobuo Ochi , Hiroki Takahashi , Yoichi Matsuo , Takehiro Wakasugi , Hiromitsu Takeyama

GDNF, uPA, MMP, pancreatic cancer

Basic research
Glial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase

Hitoshi Funahashi

,

Hirozumi Sawai

,

Akira Yasuda

,

Nobuo Ochi

,

Hiroki Takahashi

,

Yoichi Matsuo

,

Takehiro Wakasugi

,

Hiromitsu Takeyama